Endocrine disruptors and the thyroid gland--a combined in vitro and in vivo analysis of potential new biomarkers.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 2174406)

Published in Environ Health Perspect on December 01, 2007

Authors

Cornelia Schmutzler1, Inka Gotthardt, Peter J Hofmann, Branislav Radovic, Gabor Kovacs, Luise Stemmler, Inga Nobis, Anja Bacinski, Birgit Mentrup, Petra Ambrugger, Annette Grüters, Ludwik K Malendowicz, Julie Christoffel, Hubertus Jarry, Dana Seidlovà-Wuttke, Wolfgang Wuttke, Josef Köhrle

Author Affiliations

1: Institut für Experimentelle Endokrinologie, Charité - Universitätsmedizin Berlin, Berlin, Germany. cornelia.schmutzler@charite.de

Articles cited by this

Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect (1993) 10.04

Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science (2005) 10.02

Antithyroid drugs. N Engl J Med (2005) 7.43

The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr Rev (2003) 3.48

Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab (2002) 2.49

Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants. Pediatr Res (1994) 2.18

Current global iodine status and progress over the last decade towards the elimination of iodine deficiency. Bull World Health Organ (2005) 1.85

Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology (1984) 1.71

Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries. J Clin Endocrinol Metab (2004) 1.68

In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J Endocrinol Invest (2003) 1.54

Phytoestrogens: recent developments. Planta Med (2003) 1.27

Polychlorinated biphenyls and thyroid status in humans: a review. Thyroid (2003) 1.24

Environmental chemicals as thyroid hormone analogues: new studies indicate that thyroid hormone receptors are targets of industrial chemicals? Mol Cell Endocrinol (2005) 1.22

Identification of a thyroid hormone response element in the malic enzyme gene. J Biol Chem (1990) 1.21

Endocrine activity and developmental toxicity of cosmetic UV filters--an update. Toxicology (2004) 1.18

Perinatal programming and functional teratogenesis: impact on body weight regulation and obesity. Physiol Behav (2005) 1.18

The promoter of the human sodium/iodide symporter responds to certain phthalate plasticisers. Mol Cell Endocrinol (2005) 1.18

Occurrence of goiter in an infant on a soy diet. N Engl J Med (1960) 1.12

Goitrogenic content of Indian cyanogenic plant foods & their in vitro anti-thyroidal activity. Indian J Med Res (2004) 1.10

Modulation of iodide uptake by dialkyl phthalate plasticisers in FRTL-5 rat thyroid follicular cells. Mol Cell Endocrinol (2005) 1.09

A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene. Mol Cell Biol (1995) 1.09

The effects of a soybean product on thyroid function in humans. Pediatrics (1959) 1.07

Interaction of chlorinated phenols with thyroxine binding sites of human transthyretin, albumin and thyroid binding globulin. Chem Biol Interact (1990) 1.07

Tissue-specific regulation of two functional malic enzyme mRNAs by triiodothyronine. Biochemistry (1985) 1.05

Endocrine disrupters: a human risk? Mol Cell Endocrinol (2005) 1.03

Endocrine disruptors and human health: is there a problem. Toxicology (2004) 1.02

Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem (2005) 1.01

Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol (1997) 1.01

Polybrominated diphenyl ethers (PBDEs): new pollutants-old diseases. Clin Med Res (2003) 1.00

Effects of soy protein and soybean isoflavones on thyroid function in healthy adults and hypothyroid patients: a review of the relevant literature. Thyroid (2006) 1.00

Intelligence quotient and iodine intake: a cross-sectional study in children. J Clin Endocrinol Metab (2004) 0.98

Glucose and triiodothyronine both induce malic enzyme in the rat hepatocyte culture: evidence that triiodothyronine multiplies a primary glucose-generated signal. J Clin Invest (1981) 0.98

High occurrence of thyroid multinodularity and low occurrence of subclinical hypothyroidism among tobacco smokers in a large population study. J Endocrinol (2002) 0.97

Iodothyronine deiodinases. Methods Enzymol (2002) 0.97

Environmental endocrine disrupters and disorders of sexual differentiation. Semin Reprod Med (2002) 0.96

Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney. Toxicology (2004) 0.96

Amphibians as a model for the study of endocrine disruptors. Int Rev Cytol (2002) 0.95

Iodine deficiency in vegetarians and vegans. Ann Nutr Metab (2003) 0.94

Impact of environmental chemicals on the thyroid hormone function in pituitary rat GH3 cells. Mol Cell Endocrinol (2005) 0.94

The promoter of the human type I 5'-deiodinase gene--mapping of the transcription start site and identification of a DR+4 thyroid-hormone-responsive element. Eur J Biochem (1997) 0.93

Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. J Nutr (2004) 0.93

The role of thiocyanate in the etiology of goiter in an industrial metropolitan area. Eur J Endocrinol (2006) 0.92

Inhibition of rat liver iodothyronine deiodinase. Interaction of aurones with the iodothyronine ligand-binding site. J Biol Chem (1986) 0.91

Effect of various reagents including antithyroid compounds upon the activity of thyroid peroxidase. J Biochem (1963) 0.91

Developmental exposure to 4-hydroxy-2,3,3',4',5-pentachlorobiphenyl (4-OH-CB107): long-term effects on brain development, behavior, and brain stem auditory evoked potentials in rats. Toxicol Sci (2004) 0.90

Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol Appl Pharmacol (2000) 0.89

Effects of a mixture of polychlorinated biphenyls (Aroclor 1254) on the transcriptional activity of thyroid hormone receptor. J Endocrinol Invest (2003) 0.88

Hormonal response to diets high in soy or animal protein without and with isoflavones in moderately hypercholesterolemic subjects. Nutr Cancer (2005) 0.88

Inhibition of thyroid type 1 deiodinase activity by flavonoids. Food Chem Toxicol (2002) 0.88

Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditis. J Intern Med (1991) 0.87

Thiocyanate in food and iodine in milk: from domestic animal feeding to improved understanding of cretinism. Thyroid (2002) 0.84

Progress towards development of an amphibian-based thyroid screening assay using Xenopus laevis. Organismal and thyroidal responses to the model compounds 6-propylthiouracil, methimazole, and thyroxine. Toxicol Sci (2005) 0.84

Neonatal iodine deficiency: clinical aspects. J Pediatr Endocrinol Metab (2005) 0.84

Developmental effects and health aspects of soy protein isolate, casein, and whey in male and female rats. Int J Toxicol (2001) 0.83

Evaluation of histological and molecular endpoints for enhanced detection of thyroid system disruption in Xenopus laevis tadpoles. Toxicol Sci (2006) 0.83

Influence of components of oral contraceptive on lipid metabolism. Indian J Exp Biol (1996) 0.82

Cigarette smoking and the risk of goitre and thyroid nodules amongst parous women. J Intern Med (2005) 0.81

Molecular cloning and functional characterization of the human cytosolic malic enzyme promoter: thyroid hormone responsiveness. DNA Cell Biol (1997) 0.81

Genistein and other soya isoflavones are potent ligands for transthyretin in serum and cerebrospinal fluid. Br J Nutr (2006) 0.80

Risk factors for goiter in a previously iodine-deficient region. Exp Clin Endocrinol Diabetes (2005) 0.80

Flavonoid effects on transport, metabolism and action of thyroid hormones. Prog Clin Biol Res (1988) 0.80

Regulation of rat liver type 1 iodothyronine deiodinase mRNA levels by testosterone. Mol Cell Endocrinol (1995) 0.79

Multi-organic endocrine disrupting activity of the UV screen benzophenone 2 (BP2) in ovariectomized adult rats after 5 days treatment. Toxicology (2004) 0.79

Neonatal hypothyroidism due to maternal vegan diet. J Pediatr Endocrinol Metab (2005) 0.79

Differential effects of natural flavonoids on growth and iodide content in a human Na*/I- symporter-transfected follicular thyroid carcinoma cell line. Eur J Endocrinol (2004) 0.78

Dietary flavonoids and iodine metabolism. Biofactors (2003) 0.78

Estrogen induces hyperlipidemia in fasted chicks. Proc Soc Exp Biol Med (1990) 0.77

Xanthohumol stimulates iodide uptake in rat thyroid-derived FRTL-5 cells. Mol Nutr Food Res (2005) 0.77

Competitive interactions of chlorinated phenol compounds with 3,3',5-triiodothyronine binding to transthyretin: detection of possible thyroid-disrupting chemicals in environmental waste water. Toxicol Appl Pharmacol (2003) 0.77

Influence of dietary habits on thyroid status of a nomadic people, the Bororo shepherds, roaming a central African region affected by severe iodine deficiency. Eur J Endocrinol (1998) 0.77

Structure-activity relationships of flavonoid deiodinase inhibitors and enzyme active-site models. Prog Clin Biol Res (1986) 0.76

The active principles of plant extracts with antithyrotropic activity: oxidation products of derivatives of 3,4-dihydroxycinnamic acid. Endocrinology (1985) 0.76

Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins. Endocrinology (1985) 0.76

OECD test strategies and methods for endocrine disruptors. Toxicology (2004) 0.76

Age- and sex-related changes in type-1 iodothyronine deiodinase messenger ribonucleic acid in rat liver and kidney. Horm Metab Res (1999) 0.76

Consequences of iodine deficiency and preventive measures. Pediatr Endocrinol Rev (2003) 0.76

Articles by these authors

miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat Genet (2010) 4.06

Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J (2003) 2.30

Analysis of Ras-induced overproliferation in Drosophila hemocytes. Genetics (2003) 2.15

Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest (2002) 2.09

Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N Engl J Med (2008) 2.06

One triplet pregnancy in 510 controlled ovarian hyperstimulation and intrauterine insemination cycles. Fertil Steril (2003) 2.02

Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation (2011) 1.92

Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay. J Clin Endocrinol Metab (2011) 1.79

Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab (2003) 1.72

Mutations in TITF-1 are associated with benign hereditary chorea. Hum Mol Genet (2002) 1.69

Homozygosity mapping in consanguineous families reveals extreme heterogeneity of non-syndromic autosomal recessive mental retardation and identifies 8 novel gene loci. Hum Genet (2006) 1.66

Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002. J Clin Oncol (2013) 1.62

Identification of PENDRIN (SLC26A4) mutations in patients with congenital hypothyroidism and "apparent" thyroid dysgenesis. J Clin Endocrinol Metab (2013) 1.61

Hippocampal synapses depend on hippocampal estrogen synthesis. J Neurosci (2004) 1.60

Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome. Nat Genet (2003) 1.57

Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study. Eur J Endocrinol (2010) 1.48

A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab (2006) 1.46

Selenium and brain function: a poorly recognized liaison. Brain Res Brain Res Rev (2004) 1.42

Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration. FASEB J (2009) 1.41

Welcome to thyroid research. Thyroid Res (2008) 1.40

Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging (2008) 1.38

Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res (2008) 1.36

Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem J (2005) 1.36

Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environ Health Perspect (2013) 1.36

Efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase. J Biol Chem (2010) 1.29

Interleukin-11, IL-11 receptoralpha and leukemia inhibitory factor are dysregulated in endometrium of infertile women with endometriosis during the implantation window. J Reprod Immunol (2005) 1.29

Increased risk of thyroid pathology in patients with thyroid hemiagenesis: results of a large cohort case-control study. Eur J Endocrinol (2009) 1.28

Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J Neurosci (2009) 1.28

Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity -- a problem that is no longer restricted to minority groups. Eur J Endocrinol (2004) 1.28

Screening for mutations in transcription factors in a Czech cohort of 170 patients with congenital and early-onset hypothyroidism: identification of a novel PAX8 mutation in dominantly inherited early-onset non-autoimmune hypothyroidism. Eur J Endocrinol (2007) 1.26

New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol (2008) 1.24

The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency. Eur J Endocrinol (2009) 1.23

Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab (2010) 1.21

Para/autocrine regulation of estrogen receptors in hippocampal neurons. Hippocampus (2003) 1.20

Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8. Eur J Endocrinol (2005) 1.19

Efficient selenium transfer from mother to offspring in selenoprotein-P-deficient mice enables dose-dependent rescue of phenotypes associated with selenium deficiency. Biochem J (2004) 1.19

Endocrine activity and developmental toxicity of cosmetic UV filters--an update. Toxicology (2004) 1.18

Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency. Hum Mutat (2008) 1.18

The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid (2002) 1.17

Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes (2003) 1.17

Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice. Biochem J (2008) 1.16

Good prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapy. Pediatr Blood Cancer (2011) 1.11

Associations between body mass, leptin, IGF-I and circulating adrenal androgens in children with obesity and premature adrenarche. Eur J Endocrinol (2002) 1.10

Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene. J Bone Miner Res (2005) 1.10

Development of a validated liquid chromatography/tandem mass spectrometry method for the distinction of thyronine and thyronamine constitutional isomers and for the identification of new deiodinase substrates. Rapid Commun Mass Spectrom (2008) 1.05

Contribution of a membrane estrogen receptor to the estrogenic regulation of body temperature and energy homeostasis. Endocrinology (2010) 1.04

Satisfaction with genital surgery and sexual life of adults with XY disorders of sex development: results from the German clinical evaluation study. J Clin Endocrinol Metab (2011) 1.03

On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol Nutr Food Res (2008) 1.03

Mutation of megalin leads to urinary loss of selenoprotein P and selenium deficiency in serum, liver, kidneys and brain. Biochem J (2010) 1.02

Effects of bisphenol-A (BPA), dibutylphtalate (DBP), benzophenone-2 (BP2), procymidone (Proc), and linurone (Lin) on fat tissue, a variety of hormones and metabolic parameters: a 3 months comparison with effects of estradiol (E2) in ovariectomized (ovx) rats. Toxicology (2005) 1.02

Aminoglycoside pretreatment partially restores the function of truncated V(2) vasopressin receptors found in patients with nephrogenic diabetes insipidus. J Clin Endocrinol Metab (2002) 1.02

Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors. J Biol Chem (2011) 1.01

Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cells. Glia (2010) 1.01

Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture. J Nutr Biochem (2010) 1.00

Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr Cancer (2004) 1.00

Serum 25-hydroxyvitamin d and cancer risk in older adults: results from a large German prospective cohort study. Cancer Epidemiol Biomarkers Prev (2013) 0.99

Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells. Int J Oncol (2004) 0.99

Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis. Shock (2011) 0.99

Estrogen-regulated synaptogenesis in the hippocampus: sexual dimorphism in vivo but not in vitro. J Steroid Biochem Mol Biol (2011) 0.99

Arteries define the position of the thyroid gland during its developmental relocalisation. Development (2006) 0.98

Estrogen synthesis in the hippocampus. Cell Tissue Res (2011) 0.98

Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry A (2008) 0.98

Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine. J Clin Endocrinol Metab (2007) 0.98

3,5-Diiodo-L-thyronine (3,5-t2) exerts thyromimetic effects on hypothalamus-pituitary-thyroid axis, body composition, and energy metabolism in male diet-induced obese mice. Endocrinology (2015) 0.98

Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues. Endocrinology (2006) 0.98

Expression of leptin and leptin receptor isoforms in the rat and human carotid body. Brain Res (2011) 0.97

Novel insights on thyroid-stimulating hormone receptor signal transduction. Endocr Rev (2013) 0.97

Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department. Acad Emerg Med (2011) 0.97

Isoflavones--safe food additives or dangerous drugs? Ageing Res Rev (2007) 0.97

Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8. J Biol Chem (2010) 0.97

Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice. Biochim Biophys Acta (2011) 0.96

Effects of black cohosh extract on body weight gain, intra-abdominal fat accumulation, plasma lipids and glucose tolerance in ovariectomized Sprague-Dawley rats. Maturitas (2008) 0.96

Blood flow vortices along the main pulmonary artery measured with MR imaging for diagnosis of pulmonary hypertension. Radiology (2014) 0.96

Standardization of misleading immunoassay based 25-hydroxyvitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study. PLoS One (2012) 0.96

The ultraviolet filter benzophenone 2 interferes with the thyroid hormone axis in rats and is a potent in vitro inhibitor of human recombinant thyroid peroxidase. Endocrinology (2007) 0.96

Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Am J Respir Crit Care Med (2014) 0.96

Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney. Toxicology (2004) 0.96

Pharmacokinetics and metabolism of benzophenone 2 in the rat. Toxicology (2007) 0.95

Detection of 3,5-diiodothyronine in sera of patients with altered thyroid status using a new monoclonal antibody-based chemiluminescence immunoassay. Thyroid (2014) 0.95